DC Field | Value | Language |
---|---|---|
dc.contributor.author | O Song Kwon | - |
dc.contributor.author | Bo Yeon Kim | - |
dc.contributor.author | Kyoung A Kim | - |
dc.contributor.author | Min Soo Kim | - |
dc.contributor.author | Hyuncheol Oh | - |
dc.contributor.author | Beom Seok Kim | - |
dc.contributor.author | Y H Kim | - |
dc.contributor.author | Jong Seog Ahn | - |
dc.date.accessioned | 2017-04-19T09:01:48Z | - |
dc.date.available | 2017-04-19T09:01:48Z | - |
dc.date.issued | 2004 | - |
dc.identifier.issn | 0253-3073 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/6703 | - |
dc.description.abstract | The effects of hesperetin and naringenin on NF-κB activation were investigated in normal rat kidney cells transformed by temperature sensitive Rous Sarcoma Virus (tsNRK). The flavonoids, naringenin and hesperetin, significantly reduced v-Src-induced NF-κB activation as well as phosphorylation of Akt and GSK-3 in tsNRK cells, whereas these compounds did not effect on platelet-derived growth factor (PDGF)-induced NF-κB activation in NIH3T3γ1 cells. In addition, the DNA binding activity of SP-1 was also reduced but that of AP-1 was not affected by the compounds. Our study suggests that Src-induced NF-κB activation could occur via Akt-GSK-3 pathway without IκBα degradation and that naringenin and hesperetin could be used in the treatment of cancer through the inhibition of NF-κB activation. | - |
dc.publisher | Korea Soc-Assoc-Inst | - |
dc.title | Effect of the hesperetin and naringenin on pp60v-src -induced NF-κB activation = pp60v-src에 의한 NF-κB 활성화에 대한 헤스페리틴과 나린제닌의 저해 효과 | - |
dc.title.alternative | Effect of the hesperetin and naringenin on pp60v-src -induced NF-κB activation | - |
dc.type | Article | - |
dc.citation.title | Korean Journal of Pharmacognosy | - |
dc.citation.number | 3 | - |
dc.citation.endPage | 249 | - |
dc.citation.startPage | 244 | - |
dc.citation.volume | 35 | - |
dc.contributor.affiliatedAuthor | O Song Kwon | - |
dc.contributor.affiliatedAuthor | Bo Yeon Kim | - |
dc.contributor.affiliatedAuthor | Kyoung A Kim | - |
dc.contributor.affiliatedAuthor | Min Soo Kim | - |
dc.contributor.affiliatedAuthor | Hyuncheol Oh | - |
dc.contributor.affiliatedAuthor | Beom Seok Kim | - |
dc.contributor.affiliatedAuthor | Jong Seog Ahn | - |
dc.contributor.alternativeName | 권오송 | - |
dc.contributor.alternativeName | 김보연 | - |
dc.contributor.alternativeName | 김경아 | - |
dc.contributor.alternativeName | 김민수 | - |
dc.contributor.alternativeName | 오현철 | - |
dc.contributor.alternativeName | 김범석 | - |
dc.contributor.alternativeName | 김영호 | - |
dc.contributor.alternativeName | 안종석 | - |
dc.identifier.bibliographicCitation | Korean Journal of Pharmacognosy, vol. 35, no. 3, pp. 244-249 | - |
dc.subject.keyword | Akt | - |
dc.subject.keyword | flavonoid | - |
dc.subject.keyword | GSK-3 | - |
dc.subject.keyword | hesperetin | - |
dc.subject.keyword | IκBα | - |
dc.subject.keyword | naringenin | - |
dc.subject.keyword | NF-κB | - |
dc.subject.keyword | v-Src | - |
dc.subject.local | AKT | - |
dc.subject.local | Akt | - |
dc.subject.local | Flavonoid | - |
dc.subject.local | Flavonoids | - |
dc.subject.local | flavonoid | - |
dc.subject.local | flavonoids | - |
dc.subject.local | GSK-3 | - |
dc.subject.local | GSK3 | - |
dc.subject.local | Hesperetin | - |
dc.subject.local | hesperetin | - |
dc.subject.local | IκB-α | - |
dc.subject.local | IκBa | - |
dc.subject.local | IκBα | - |
dc.subject.local | Naringenin | - |
dc.subject.local | naringenin | - |
dc.subject.local | NFkappaB | - |
dc.subject.local | NFκB | - |
dc.subject.local | Nf-κB | - |
dc.subject.local | Nf-κb | - |
dc.subject.local | Nuclear factor (NF)-κB | - |
dc.subject.local | Nuclear factor kappa B | - |
dc.subject.local | Nuclear factor kappaB | - |
dc.subject.local | Nuclear factor κB | - |
dc.subject.local | Nuclear factor κB (NF-κB) | - |
dc.subject.local | Nuclear factor-kappa B | - |
dc.subject.local | Nuclear factor-kappa B (NF-κB) | - |
dc.subject.local | Nuclear factor-kappaB | - |
dc.subject.local | Nuclear factor-κB | - |
dc.subject.local | Nuclear factor-κb | - |
dc.subject.local | NF-kB | - |
dc.subject.local | NF-kappa B | - |
dc.subject.local | NF-kappaB | - |
dc.subject.local | NF-ΚB | - |
dc.subject.local | NF-κ B | - |
dc.subject.local | NF-κB | - |
dc.subject.local | NF-κB (nuclear factor kappa-B) | - |
dc.subject.local | nuclear factor kappa B | - |
dc.subject.local | nuclear factor κB | - |
dc.subject.local | nuclear factor-kappaB | - |
dc.subject.local | nuclear factor-kappaB (NF-κB) | - |
dc.subject.local | nuclear factor-κB | - |
dc.subject.local | nuclear factorκB | - |
dc.subject.local | v-Src | - |
dc.subject.local | v-src | - |
dc.description.journalClass | N | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.